Skip Nav Destination
Benefits and risks of JAK inhibition
Non-zero-sum game of transfusions: EOL in leukemia
l-Glutamine for sickle cell anemia: more questions than answers
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine
Issue Archive
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Benefits and risks of JAK inhibition
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Non-zero-sum game of transfusions: EOL in leukemia
Clinical Trials & Observations
PERSPECTIVE
BLOOD SPOTLIGHT
l-Glutamine for sickle cell anemia: more questions than answers
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Clinical Trials & Observations
Edit Porpaczy,Sabrina Tripolt,Andrea Hoelbl-Kovacic,Bettina Gisslinger,Zsuzsanna Bago-Horvath,Emilio Casanova-Hevia,Emmanuelle Clappier,Thomas Decker,Sabine Fajmann,Daniela A. Fux,Georg Greiner,Sinan Gueltekin,Gerwin Heller,Harald Herkner,Gregor Hoermann,Jean-Jacques Kiladjian,Thomas Kolbe,Christoph Kornauth,Maria-Theresa Krauth,Robert Kralovics,Leonhard Muellauer,Mathias Mueller,Michaela Prchal-Murphy,Eva Maria Putz,Emmanuel Raffoux,Ana-Iris Schiefer,Klaus Schmetterer,Christine Schneckenleithner,Ingrid Simonitsch-Klupp,Cathrin Skrabs,Wolfgang R. Sperr,Philipp Bernhard Staber,Birgit Strobl,Peter Valent,Ulrich Jaeger,Heinz Gisslinger,Veronika Sexl
Publisher's Note: There is a Blood Commentary on this article in this issue.
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)
Clinical Trials & Observations
Hervé Decousus,Aurélie Bourmaud,Pierre Fournel,Laurent Bertoletti,Carine Labruyère,Emilie Presles,Adel Merah,Silvy Laporte,Laetitia Stefani,Francesco Del Piano,Jean-Philippe Jacquin,Guy Meyer,Franck Chauvin,for the ONCOCIP Investigators
LYMPHOID NEOPLASIA
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations
e-blood
Sarah C. Rutherford,Angela A. Fachel,Sheng Li,Seema Sawh,Ashlesha Muley,Jennifer Ishii,Ashish Saxena,Pilar M. Dominguez,Eloisi Caldas Lopes,Xabier Agirre,Nyasha Chambwe,Fabian Correa,Yanwen Jiang,Kristy L. Richards,Doron Betel,Rita Shaknovich
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment
Simranpreet Kaur,Liza J. Raggatt,Susan M. Millard,Andy C. Wu,Lena Batoon,Rebecca N. Jacobsen,Ingrid G. Winkler,Kelli P. MacDonald,Andrew C. Perkins,David A. Hume,Jean-Pierre Levesque,Allison R. Pettit
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study
CME
Clinical Trials & Observations
Brief Report
Regis Peffault de Latour,Sylvie Chevret,Charlotte Jubert,Anne Sirvent,Claire Galambrun,Annalisa Ruggeri,Virginie Gandemer,Jérôme Cornillon,Fanny Rialland,Jean-Hugues Dalle,Edouard Forcade,Benedicte Bruno,Catherine Paillard,Pierre S. Rorlich,Alexandra Salmon,Sabine Fürst,Flore Sicre de Fontbrune,Marie Therese Rubio,Jacques-Olivier Bay,Mohamad Mohty,Jerome Larghero,Eliane Gluckman,Gerard Socié,on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
LETTERS TO BLOOD
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
Clinical Trials & Observations
Yuma Sakamoto,Takashi Ishida,Ayako Masaki,Takayuki Murase,Kentaro Yonekura,Yukie Tashiro,Masahito Tokunaga,Atae Utsunomiya,Asahi Ito,Shigeru Kusumoto,Shinsuke Iida,Ryuzo Ueda,Hiroshi Inagaki
Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine
Clinical Trials & Observations
Richa Manwani,Sajitha Sachchithanantham,Shameem Mahmood,Darren Foard,Faye Sharpley,Tamer Rezk,Thirusha Lane,Cristina Quarta,Marianna Fontana,Helen J. Lachmann,Julian D. Gillmore,Carol Whelan,Philip N. Hawkins,Ashutosh D. Wechalekar
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
Hematoxylin and eosin–stained peripheral blood smear from Stat1−/− mice. Notice the expansion of myeloid cells indicating a myeloproliferative disease. Stat1−/− mice develop a myeloid hyperplasia as they age. Transplantation of bone marrow from diseased Stat1−/− mice provokes the outgrowth of an aggressive B-cell clone in recipient mice that is already detectable in the donor Stat1−/− mice. See the article by Porpaczy et al on page 694.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement